In recent years, cannabis investors have seen a rush of options become available on the Canadian Securities Exchange (CSE) thanks to a critical ruling from exchange operators.
The exchange has positioned itself as one of the pillars of marijuana investment in Canada, offering Canadian companies the option to seek business possibilities in the US, as long as they disclose risks properly to shareholders.
The cannabis market really accelerated for the CSE after TMX Group imposed a regulation preventing companies listed on the TSX and TSX Venture Exchange from holding US assets. Cannabis is currently illegal in the US at the federal level; however, it has become legal medically and recreationally in many states.
The CSE now offers exposure to a wide range of cannabis stocks, from those in the early stages of development to established multi-state operators (MSOs). It is also home to a variety of research operations and extraction firms.
Here the Investing News Network offers investors a growing list of all the cannabis-related companies listed on the CSE.
1933 Industries (CSE:TGIF,OTCQB:TGIFF)
This vertically integrated company operates assets in both the Canadian and US cannabis markets, focusing on cultivation, extraction and production of hemp-derived items.
4Front Ventures has established cannabis cultivation, production, manufacturing and retail operations across the US, including six cultivation and manufacturing facilities in Washington, Illinois and Massachusetts. It also has licenses in place enabling it to develop manufacturing facilities in both Arizona and California.
Acreage Holdings (CSE:ACRG.A.U,OTCQX:ACRHF)
Acreage Holdings is one of the largest MSOs in the US market. This company has an acquisition deal in place with Canopy Growth (TSX:WEED,NASDAQ:CGC) that will take effect once marijuana becomes legal in the US at the federal level.
Adastra Labs Holdings (CSE:XTRX)
Adastra Labs Holdings is a standard cannabis processor and analytical testing laboratory in Canada, and intends to become a one-stop-shop for cannabis concentrates and value-added cannabis products.
Affinor Growers (CSE:AFI,OTCQB:RSSFF)
This company offers agricultural technology to clients looking to improve their food-growing businesses. As part of its cannabis operations, the firm offers specialized lights for the growing of marijuana.
AgraFlora Organics International (CSE:AGRA,OTC Pink:AGFAF)
This vertically integrated cannabis company oversees cultivation assets in Canada for production and operates a variety of brands in various aspects of the market.
AMP German Cannabis Group (CSE:XCX)
AMP German Cannabis Group is licensed to import European Union Good Manufacturing Practice medical cannabis from Europe and elsewhere into Germany. AMP sources, stores, transports, delivers and sells medical cannabis products to pharmaceutical distributors or pharmacists directly.
AREV NanoTec Brands (CSE:AREV,OTC Pink:AREVF)
This specialty natural health product company plans to develop items in the cannabis market targeting the health and wellness space.
Asia Green Biotechnology (CSE:ASIA)
This early stage company uses its agriculture technologies for growing hemp in Southeast Asia.
Australis Capital (CSE:AUSA,OTCQB:AUSAF)
A spinoff from Aurora Cannabis (TSX:ACB,NYSE:ACB), this firm is designed to provide investments in the overall cannabis market, including operations in the US and internationally.
Ayr Wellness (CSE:AYR.A,OTCQX:AYRWF)
Ayr Wellness is a vertically integrated US cannabis MSO focused on high-growth markets. The company cultivates and manufactures branded cannabis products for distribution through its network of retail outlets and through third-party stores.
BC Craft Supply (CSE:CRFT,OTC Pink:CRFTF)
BC Craft Supply supports trusted cannabis cultivators in Canada to transition into their supply chain. In exchange for support with licensing, compliance and distribution, cultivators sign on as BC Craft suppliers.
Benchmark Botanics (CSE:BBT)
This Canadian cannabis producer has cultivation operations in Peachland, BC. It also produces cannabis extracts such as oils.
Better Plant Sciences (CSE:PLNT)
Better Plant Sciences develops and acquires intellectual property and other assets related to plant-based products and therapeutics. The company develops, manufactures, markets, sells and distributes plant-based products, and owns over 400 proprietary product formulas.
As its name indicates, this company is focused on the development of cannabis-infused beverages for consumers, and the development of the brands attached to these drinks.
Bhang is a cannabis brand company operating a significant portfolio of cannabis, hemp-derived cannabidiol (CBD) and terpene products.
BioHarvest Sciences is targeting the international market demand for natural products that provide consumers with functional health and wellness. This includes consumer products ranging from foods enriched with active ingredients like antioxidants, to cleaner and more consistent cannabis products.
Biome Grow (CSE:BIO,OTCQB:BIOIF)
Thanks to its subsidiaries, this company has a cultivation-to-distribution business model with its cannabis operations in Atlantic Canada.
Blueberries Medical (CSE:BBM,OTCQB:BBRRF)
This international cannabis company is a producer in Latin America with licensed operations in Colombia and new assets in Argentina.
Bluma Wellness (CSE:BWEL.U,OTC Pink:BMWLF)
Bluma Wellness is a vertically integrated licensed medical cannabis company operating in Florida through its subsidiary 3 Boys Farm, doing business as One Plant Florida.
Body and Mind (CSE:BAMM,OTCQB:BMMJ)
Through its Nevada-based subsidiary, Body and Mind produces marijuana products such as dried flower, oil extracts and edible items.
C21 Investments (CSE:CXXI,OTCQX:CXXIF)
C21 Investments is a vertically integrated cannabis company with a direct focus on the US market thanks to its operations in Oregon.
Canada House Cannabis Group (CSE:CHV)
This company utilizes the value of its subsidiaries to pursue the cannabinoid therapy market.
CanaFarma Hemp Products (CSE:CNFA)
CanaFarma Hemp Products is a full-service company operating in the hemp industry offering a full range of hemp-related products and services.
Canbud Distribution (CSE:CBDX)
Science and technology company Canbud Distribution specializes in the clone-to-consumer hemp value chain, as well as psychedelic microdosing, functional mushrooms, nutraceuticals and plant-based proteins.
Cannabix Technologies (CSE:BLO,OTC Pink:BLOZF)
This technology company is actively developing breath-testing devices that offer guaranteed detection of marijuana use in impaired drivers.
CannAmerica Brands (CSE:CANA,OTC Pink:CNNXF)
This company uses the brands in its portfolio to offer consumers specialty products. CannAmerica Brands has operations in Colorado, Nevada and Maryland.
CannaOne Technologies (CSE:CNNA,OTC Pink:CNONF)
This cannabis technology company offers clients the BloomKit, a business-to-business (B2B) software platform designed to offer high functionality for retail and online operations.
Canntab Therapeutics (CSE:PILL,OTCQB:CTABF)
This Ontario-based oral dosage formulation company researches and develops advanced pharmaceutical-grade formulations of cannabinoids.
This MSO is based in Florida, but manages assets across the US, including in Pennsylvania and Puerto Rico.
Captiva Verde Land (CSE:PWR)
A newcomer to the public markets, this company is a real estate investment firm with cannabis assets in New Brunswick.
Captor Capital (CSE:CPTR)
Captor Capital is a vertically integrated cannabis investment company focused on the US marijuana market and looking for exposure across the industry’s supply chain.
CBD Global Sciences (CSE:CBDN,OTC Pink:CBDNF)
CBD Global Sciences is a vertically integrated hemp-based CBD producer, extractor and branding investment vehicle that currently owns two product categories branded under the names AETHICS and CANNAOIL. These include CBD oil tinctures, CBD capsules and CBD topicals.
Chemesis International (CSE:CSI,OTCQB:CADMF)
Chemesis International is a vertically integrated cannabis company with operations in Puerto Rico and California.
Chemistree Technology (CSE:CHM,OTCQB:CHMJF)
This cannabis investment company looks for exposure to the US cannabis market and seeks to offer turnkey solutions for the legal industry.
Choom Holdings (CSE:CHOO,OTCQB:CHOOF)
Choom Holdings is a retail operator of marijuana dispensaries in Canada looking to leverage its expertise with new stores in North America.
Christina Lake Cannabis (CSE:CLC,OTCQB:CLCFF)
Christina Lake Cannabis is a licensed cannabis producer in British Columbia that offers sun-grown cannabis flower, oil cannabinoids and hemp-based extracts and derivatives to the domestic and international markets.
City View Green Holdings (CSE:CVGR,OTCQB:CVGRF)
This early stage cannabis company seeks to operate a growth, extraction, production and retail business cycle model with vertical integration.
CLS Holdings USA (CSE:CLSH,OTCQB:CLSH)
This cannabis company holds a dispensary operation in Nevada and is targeting an entry to Massachusetts. The firm credits its proprietary extraction technology for its results.
Columbia Care (CSE:CCHW,OTCQX:CCHWF)
Columbia Care is one of the largest and most experienced cultivators, manufacturers and providers of medical and adult-use cannabis products and related services. It has licenses in 18 US jurisdictions and in the EU.
This Canadian cannabis company offers services related to the processing side of the marijuana space.
Cresco Labs (CSE:CL,OTCQX:CRLBF)
One of the leading MSOs in the public space, Cresco Labs has gained the attention of investors and analysts thanks to its rapid expansion across legal state cannabis markets.
Curaleaf Holdings (CSE:CURA,OTCQX:CURLF)
Curaleaf Holdings is another leading MSO in the public markets. It has a large portfolio of cannabis assets across the legal US state markets, including Arizona, Connecticut, Florida, Maine, Maryland, Massachusetts, Nevada, New Jersey, New York and Oregon.
Discover Wellness Solutions (CSE:WLNS,OTC Pink:WLNSF)
Discover Wellness Solutions is a cannabis company working to obtain a cultivation license in Canada through its subsidiary Rocky Mountain Marijuana.
This company is based in Canada, but has operations in Africa and Europe. Through its subsidiaries, the firm focuses on sustainable cultivation of marijuana and hemp for the production of pharmaceutical-grade products.
FinCanna Capital (CSE:CALI,OTCQB:FNNZF)
FinCanna Capital is a royalty finance company evaluating the cannabis market in the US, with a direct interest in California. The company offers access to capital for companies as part of a royalty payment methodology.
Fiore Cannabis (CSE:FIOR,OTCQX:FIORF)
Fiore Cannabis is an MSO running a state-of-the-art cultivation and production facility in Nevada and an award-winning dispensary focused on cannabis wellness products in California.
Flower One Holdings (CSE:FONE,OTCQX:FLOOF)
Flower One Holdings is a cannabis company based in Nevada with full-service cultivation operations all the way into processing and packaging. The company manages key retail brands to expand its business.
GABY is a pure-play health and wellness company looking to sell CBD-infused products to consumers in the mainstream grocery environment.
Michigan cannabis cultivator, retailer and brand Gage Growth operates three licensed cultivation and processing facilities, and has 10 contract grow agreements in place. Gage also operates seven dispensaries throughout the state.
Gaia Grow (CSE:GAIA)
Gaia Grow is a licensed cultivator of industrial hemp. Through contract farming the company uses existing farmland and skilled farmers to cultivate industrial hemp, which it then sells to processors to be turned into hemp fiber and CBD oil and concentrates.
Global Cannabis Applications (CSE:APP,OTCQB:FUAPF)
The company seeks patients looking for more advanced cannabis-based medicines through its Citizen Green Technology Platform, which aims to find candidates for clinical studies.
Global Health Clinics (CSE:MJRX)
This company operates under a two part business model of creating and generating leads for cannabis producers in Canada alongside ancillary businesses, as well as connecting medical patients with producers.
Global Hemp Group (CSE:GHG,OTCQB:GBHPF)
Global Hemp Group is seeking a market share in the industrial hemp market in North America through two phases of development.
This company is a Canadian merchant bank that provides medical cannabis companies across the globe with funding solutions.
Gnomestar Craft (CSE:GNOM)
Gnomestar Craft is a craft cannabis producer in BC. The company operates a 12,000 square foot indoor facility and is growing proprietary cultivars for the adult-use recreational cannabis market.
Golden Leaf Holdings (CSE:GLH,OTCQB:GLDFF)
Golden Leaf Holdings is a cannabis oil and solutions provider in North America with operations in Oregon, Nevada and Canada.
Green Thumb Industries (CSE:GTII,OTCQX:GTBIF)
Green Thumb Industries is a Chicago-based MSO with cannabis operations across the legal US state markets, including a dispensary network.
Grown Rogue International (CSE:GRIN)
Grown Rogue International is a cannabis company in the US with critical assets in California, Oregon and Michigan. It offers branded marijuana products.
Co-founded by cannabis activist and leader Steve DeAngelo, this company has established a presence in the California market and went public in Canada after completing a reverse takeover.
Harvest Health & Recreation (CSE:HARV,OTCQX:HRVSF)
This MSO has a significant footprint across the US marijuana market through the management of cultivation and retail assets in legal state markets.
Hemp for Health (CSE:HFH)
Hemp for Health is a cultivator and distributor of premium CBD products with an exclusive, long-term contract for land with farmers in the Tuscan region of Italy for the purpose of yielding the highest-quality hemp-based CBD.
Heritage Cannabis Holdings (CSE:CANN,OTCQX:HERTF)
This cannabis company has completed a variety of acquisitions to pursue its target of becoming a vertically integrated operator with cultivation, extraction and branding assets.
Hollister Biosciences (CSE:HOLL,OTC Pink:HSTRF)
Hollister Biosciences is a cannabis MSO that is developing a premium brand portfolio of high-quality cannabis and hemp products by controlling the whole process, from manufacturing to sales to distribution.
iAnthus Capital Holdings (CSE:IAN,OTC Pink:ITHUF)
After successfully completing the acquisition of the US assets from a fellow cannabis company, iAnthus Capital Holdings has expanded its footprint as an MSO across the US.
Icanic Brands Company (CSE:ICAN,OTCQB:ICNAF)
Icanic Brands Company is a cannabis company with operations in California and Nevada. It exclusively sells branded products.
Ignite International Brands (CSE:BILZ,OTCQX:BILZF)
Ignite International Brands is a vertically integrated cannabis company focused on premium brand development across the markets in which it operates.
IM Cannabis (CSE:IMCC,NASDAQ:IMCC)
IM Cannabis is an Israel-based cannabis operator that offers medical products in the country and holds a subsidiary in Germany to distribute its offerings in the European market.
Through its subsidiaries, INDVR Brands cultivates, processes and markets cannabis. The company offers cannabis asset acquisition, brand development and distribution services.
Inner Spirit Holdings (CSE:ISH,OTC Pink:INSHF)
Inner Spirit Holdings is a cannabis retailer operating its Spiritleaf dispensary brand of marijuana stores across the Canadian market.
Innocan Pharma (CSE:INNO,OTCQB:INNPF)
Innocan Pharma is a pharmaceutical tech company that focuses on the development of several drug delivery platforms that combining CBD with other pharmaceutical ingredients.
Isracann Biosciences (CSE:IPOT,OTC Pink:ISCNF)
Isracann Biosciences is the first enterprise-scale farm-to-consumer cannabis project in Israel.
Jushi Holdings (CSE:JUSH,OTCQB:JUSHF)
Jushi Holdings is a globally focused cannabis and hemp company. In the US, Jushi is focused on building a multi-state portfolio of branded cannabis and hemp-derived assets through opportunistic acquisitions, distressed workouts and competitive applications.
This biotechnology company employs its patented DehydraTECH technology as the basis for its platform offerings. TurboCBD is a high-absorption, full-spectrum hemp oil capsule, and ChrgD+ is a water-soluble and ready-to-mix hemp supplement powder packet.
Lotus Ventures (CSE:J)
This Canadian cannabis producer is targeting high-end consumers with its Lotus Cannabis brand. The firm has an offtake agreement with Auxly Cannabis Group (TSXV:XLY,OTCQX:CBWTF).
Lowell Farms (CSE:LOWL,OTCQX:LOWLF)
Lowell Farms is a US-based, vertically integrated cannabis company with production operations. It also oversees the development of branded products.
Luff Enterprises (CSE:LUFF)
Luff Enterprises is a CBD lifestyle company that manufactures and distributes hemp-based cannabinoid wellness products in the US.
ManifestSeven Holdings (CSE:MSVN)
ManifestSeven Holdings operates an integrated omnichannel platform for legal cannabis, merging compliant distribution with retail.
Thanks to its subsidiary, this firm cultivates cannabis in Quebec with plans for further expansion. The company is also pursuing alternative delivery methods for cannabis such as topical products.
MedMen Enterprises (CSE:MMEN,OTCQX:MMNFF)
MedMen Enterprises is an MSO that has been able to gain the attention of the California market thanks to its dispensaries and popular marketing. The firm has operations across the US and wants to expand the reach of its brand.
MedXtractor is a technology and marketing company engaged in selling and manufacturing proprietary carbon dioxide-based extractors that are used to extract essential oils and compounds from various botanical materials, including for the production of high-potency, high-purity medical cannabis extracts.
MJardin Group (CSE:MJAR,OTC Pink:MJARF)
MJardin Group is a cannabis management platform company operating over 30 cannabis operations.
Mojave Brands (CSE:MOJO)
This Canadian cannabis company has operations in the US cannabis market through the management of its distribution subsidiary in the California cannabis industry.
Molecule Holdings (CSE:MLCL)
Molecule Holdings works with its clients to engage in the production of cannabis-infused beverages and edibles. The company provides the infrastructure, know-how, technology and licensing for craft producers to create consumable cannabis products.
MPX International (CSE:MPXI,OTCQB:MPXOF)
After selling its US assets, this firm is focused on the development of its Canadian facility and an expansion into the European market.
MustGrow Biologics (CSE:MGRO,OTCQX:MGROF)
MustGrow Biologics is an agricultural biotech company focused on developing and commercializing its unique natural biopesticide, which acts as a pesticide, fumigant, fertilizer, nematocide and fungicide. The company is targeting the fruit, vegetable and cannabis industries.
MYM Nutraceuticals (CSE:MYM,OTCQB:MYMMF)
MYM Nutraceuticals is a cannabis grower with operations in Canada. It is looking to distribute its products at the global level.
Nabis Holdings (CSE:NAB)
Nabis Holdings is a Canadian investment company focused on investing in strategic assets across multiple verticals of the cannabis sector, primarily in US limited license states.
NanoSphere Health Sciences (CSE:NSHS)
This nano-biotechnology company brings a unique approach to the cannabis market thanks to its advanced delivery technology, which increases the effectiveness and longevity of cannabinoids in products.
Nass Valley Gateway (CSE:NVG)
This medical company gains exposure to the marijuana market thanks to its planned sale of pain-relieving, CBD-infused products.
Next Green Wave Holdings (CSE:NGW,OTCQB:NXGWF)
Next Green Wave Holdings is a vertically integrated cannabis company with producing assets and a portfolio of brands in California.
Nextleaf Solutions is a cannabis extraction and technology company looking to license its methodologies as it offers an industrial-scale process of producing purified cannabinoid distillate.
Nutritional High International (CSE:EAT,OTC Pink:SPLIF)
This marijuana company is focused on the development of edible products and oil extracts for the US medical and recreational markets.
Orchid Ventures (CSE:ORCD,OTC Pink:ORVRD)
This company develops and sells vaporizers in California and Nevada through a B2B and wholesale business model. It seeks to expand its presence in the US market.
Ovation Science (CSE:OVAT,OTCQB:OVATF)
Ovation Science gets a share in the cannabis market thanks to its drug delivery technology for topical and transdermal skin products with hemp and cannabis oil.
Pac Roots Cannabis is focused on the development of premium cannabis genetics to maximize product quality and crop yields.
Planet 13 Holdings (CSE:PLTH,OTCQX:PLNHF)
This cannabis company has a specific focus on the Nevada market with cultivation and retail assets. The firm manages a mega-store dispensary in Las Vegas, and plans to develop another shop in California.
Plant-based Investment (CSE:PBIC,OTC Pink:CWWBF)
This investment company is looking to offer its investors returns from bets placed in an actively managed portfolio of assets across the marijuana space.
Plus Products (CSE:PLUS,OTCQX:PLPRF)
Plus Products specializes in the production and development of branded edible products sold in the California market.
POSaBIT Systems (CSE:PBIT,OTC Pink:POSAF)
This company incorporates blockchain technology to offer a turnkey solution for transparency in production and compliancy issues in the cannabis space.
BC-based cannabis retailer Quantum 1 Cannabis currently has six retail licenses. It is focused on delivering value-added customer experiences, premium products and unparalleled service and education.
Quinsam Capital (CSE:QCA)
Quinsam Capital is a merchant bank offering a variety of options to companies; it also invests in areas it believes are undervalued.
Radiko Holdings (CSE:RDKO)
Radiko Holdings develops cannabis products and, through its subsidiaries, sells edible cannabis consumables, as well as ancillary products including clothing, paraphernalia and posters.
Red White & Bloom Brands (CSE:RWB,OTCQX:RWBYF)
Red White & Bloom Brands is a cannabis MSO active in the US legal cannabis and hemp sectors. The company is predominantly focused on major US cannabis markets, including Michigan, Illinois, California, Oklahoma, Arizona and Massachusetts,
Rockshield Capital (CSE:RKS,OTC Pink:RKSCF)
This is an early stage venture capital fund and merchant bank company that has added some cannabis interests to its portfolio, including The Green Organic Dutchman (TSX:TGOD,OTCQX:TGODF) and Halo Collective (NEO:HALO,OTCQB:HCANF).
Sativa Wellness Group (CSE:SWEL,OTC Pink:SCNNF)
Sativa Wellness Group is an early stage life science company focused on hemp cultivation, extraction and formulation, as well as CBD products. It is targeting the European CBD and wellness market.
Sire Bioscience is a life science company focused on the cultivation, production and sale of industrial hemp.
SLANG Worldwide (CSE:SLNG,OTCQB:SLGWF)
This cannabis company seeks to acquire brands to expand its portfolio with market-proven product that can attract consumers.
SOL Global Investments (CSE:SOL,OTC Pink:SOLCF)
This cannabis investment company leverages its holdings across the industry, but has a direct focus on the US market.
SpeakEasy Cannabis (CSE:EASY)
The company owns facilities that are looking to become licensed producers of cannabis in Canada. It is also planning for expansion.
Sproutly Canada (CSE:SPR,OTCQB:SRUTF)
Sproutly Canada is a cannabis company working on the development of cannabis-infused drinks thanks to its proprietary technology and a joint venture partnership with Moosehead Breweries.
Stem Holdings (CSE:STEM,OTCQX:STMH)
Stem Holdings is a vertically integrated cannabis company with assets in Nevada, Oklahoma and Oregon. The firm oversees a variety of brands in the US market.
Sweet Earth Holdings (CSE:SE,OTCQB:SEHCF)
Oregon-focused Sweet Earth Holdings is a vertically integrated hemp company cultivating organic CBD products that are sustainably grown without the use of pesticides, herbicides or chemical fertilizers.
This Quebec-based cannabis company has subsidiaries with cultivation facilities producing medical and recreational cannabis for the Canadian market.
TerrAscend is a vertically integrated operator of cannabis assets in North America with investments in the Canadian and US cannabis markets. The company has an investment partnership with Canopy Rivers (TSXV:RIV,OTC Pink:CNPOF).
THC Biomed (CSE:THC,OTCQX:THCBF)
This cannabis company holds cultivation assets in Canada and is developing new scientific research for its medical products.
Thoughtful Brands (CSE:TBI, OTCQB:PEMTF)
Thoughtful Brands is an ecommerce technology company that researches, develops, markets and distributes natural health products, including the Nature’s Exclusive brand, in North America.
TILT Holdings (CSE:TILT,OTCQX:TLLTF)
TILT Holdings is a vertically integrated technology company offering business to the cannabis industry through its software platform.
Tinley Beverage (CSE:TNY,OTCQX:TNYBF)
Tinley Beverage is a beverage company developing hemp-infused beverages and supplements for the US market.
Top Strike Resources (CSE:VENI,OTCQB:TPPRF)
Top Strike Resources aims to provide capital to early stage global cannabis initiatives.
Thanks to its subsidiaries, this all-around cannabis company is working with clients in the California market on a business ecosystem of branding and design, transport and distribution and sales and marketing.
Tree of Knowledge International (CSE:TOKI,OTC Pink:TOKIF)
Tree of Knowledge International is a diversified company based in Toronto. It is working on the treatment of chronic pain through cannabis, the production of formulated natural products and the distribution of hemp-based CBD items.
True Leaf Brands (CSE:MJ,OTC Pink:TRLFF)
This company develops natural hemp products designed for humans and pets.
Trulieve Cannabis (CSE:TRUL,OTCQX:TCNNF)
Trulieve Cannabis is an MSO based in Florida with a leading position in the sunshine state. The firm has expressed interest in expanding, with acquisitions in California and Massachusetts.
TruTrace Technologies (CSE:TTT,OTC Pink:TTTSF)
TruTrace Technologies incorporates a software aspect into the cannabis market by bringing its blockchain-based program that tracks cannabis intellectual property all across the sale chain.
Veritas Pharma (CSE:VRT)
Veritas Pharma is a company conducting research for medicinal cannabis therapies, products and services.
Vext Science (CSE:VEXT,OTCQX:VEXTF)
Vext Science is a US-based cannabis THC and hemp cannabinoid products company manufacturing THC cartridges, concentrates, edibles and accessories under the Vapen brand. It also makes hemp-based products under the Pure Touch Botanicals brand, as well as the Vapen CBD brand.
Vibe Growth (CSE:VIBE,OTC Pink:VBSCF)
Vibe Growth is a vertically integrated cannabis company operating a cannabis retail network in California.
Vireo Health International (CSE:VREO,OTCQX:VREOF)
Vireo Health International is looking to expand its suite of assets as an MSO in the US cannabis market. The firm manages greenhouses, sells its own branded products and operates retail assets.
This company offers investors a diversified portfolio of cannabis brands in markets such as California, Washington state, British Columbia and Las Vegas. It has a specific focus on dried flower, edibles and extract products.
Wikileaf Technologies (CSE:WIKI)
Wikileaf Technologies is a Seattle business providing data services to the cannabis industry and information to consumers. The company provides price indexes and cannabis strain reviews and information.
Wildflower Brands (CSE:SUN,OTC Pink:WLDFF)
This house-of-brands company seeks to develop new branded products in the health and wellness market across the US. The firm also has a presence in Poland and Canada.
After completing its acquisition of Quadron Cannatech, World Class Extractions gained a stronger stance on the cannabis and hemp extraction markets with patent-pending technology for improved oils.
XPhyto Therapeutics (CSE:XPHY,OTCQB:XPHYF)
XPhyto Therapeutics is researching novel drug-delivery technologies and holds subsidiaries in the European market that are involved in trials for a CBD drug treating epilepsy.
XS Financial (CSE:XSF,OTCQB:XSHLF)
XS Financial is a direct lender that provides flexible leasing solutions exclusively to the cannabis industry.
Want more details on Canadian cannabis stocks? Check out these articles for more INNdepth coverage:
- Invest in Cannabis: TSX Cannabis Stocks
- Cannabis Companies: Stocks on the TSXV
- Cannabis Investment: Canadian Cannabis Stocks
Want an overview of investing in cannabis stocks? Check out Investing in the Cannabis Industry.
The Australian cannabis market has been maturing since medical marijuana was federally legalised in 2016.
The next year, Food Standards Australia New Zealand legalised low-THC hemp food for human consumption in Australia. The country went on to legalise medical marijuana exports in 2018, allowing medicinal marijuana products developed in Australia to be exported to licenced recipients in countries where the drug is legal.
Recreational cannabis remains federally illegal in the country, but recent legislation shows the door may be opening. In 2019, the Australian Capital Territory passed a bill allowing for the possession and growth of small amounts of cannabis for personal use. The law went into effect on January 31, 2020.
More recently, in late 2020, the Therapeutic Goods Administration greenlit the sale of low-dose cannabidiol (CBD) through over-the-counter methods without a prescription. The ruling from the Australian regulatory agency is expected to officially come into effect in February 2021.
With these and other changes in the works, Australia’s cannabis industry is projected to have long-term potential. The legal cannabis market in Oceania is expected to be worth US$1.55 billion by 2024, with Australia accounting for 79 percent of the region’s market, Prohibition Partners forecasts.
According to a study from FreshLeaf Analytics, the value of the medical market in Australia reached AU$95 million in 2020, and the firm expects revenue to jump again to over AU$150 million in 2021. In short, Australia’s role in the global cannabis industry will certainly continue to grow.
Here the Investing News Network profiles 10 ASX cannabis stocks with market caps between AU$30 million and AU$225 million. All ASX cannabis stocks below are listed in order of market capitalization from largest to smallest, with data compiled using TradingView’s stock screener on January 12, 2021.
1. Creso Pharma (ASX:CPH)
Market cap: AU$209.83 million
Creso Pharma was the first company to import medical cannabis into Australia and the first to launch these products in Switzerland for people, as well as animals. The cannabis company’s anibidiol product was the first hemp CBD complementary feed in animal health thanks to a partnership with Virbac Switzerland. Creso Pharma has also launched cannaQIX in Switzerland; it was the first CBD nutraceutical in human health.
The company’s medicinal cannabis product lines cover therapeutics, nutraceuticals, animal health, lifestyle and topicals.
2. Cann Group (ASX:CAN)
Market cap: AU$176.84 million
Cann Group provides a range of medicinal cannabis products for patients in Australia and globally. In 2017, the company was granted Australia’s first cannabis research licence, as well as the first medicinal marijuana cultivation licence. Cann Group partners with leading medical scientists in Australia to research and harness the therapeutic potential of cannabinoids, terpenes and other bioactive constituents of cannabis.
The company has secured supply agreements in global cannabis markets, including the UK, Germany and other European segments.
3. Incannex Healthcare (ASX:IHL)
Market cap: AU$166.42 million
Incannex Healthcare is a clinical-stage cannabinoid medicine company with global export capacity. It has four clinical programs underway for the development of a variety of cannabis medicinal products aimed at major unmet medical needs, including obstructive sleep apnea, traumatic brain injury/concussion, sepsis-associated acute respiratory distress syndrome and temporomandibular joint disorder.
In 2020, the company worked to advance its clinical trials. By the second half of the year, cannabinoid products accounted for Incannex’s entire revenue stream.
4. Botanix Pharmaceuticals (ASX:BOT)
Market cap: AU$131.37 million
Botanix Pharmaceuticals has a product pipeline that includes three advanced clinical programs using synthetic cannabidiol for the topical treatment of serious skin diseases and for antimicrobial applications. The company also has an exclusive licence to use a proprietary drug-delivery system called Permetrex for direct skin delivery of pharmaceuticals.
Botanix Pharmaceuticals’ programs are focused on treating acne, rosacea, atopic dermatitis and microbial infection. The company secured a clear development path for its BTX 1801 synthetic cannabidiol antimicrobial product after the successful completion of a pre-investigational new drug meeting with the US Food and Drug Administration.
5. Althea Group Holdings (ASX:AGH)
Market cap: AU$114.2 million
Althea Group Holdings takes the concept of medical cannabis a step further with its work as a pharmaceutical-grade cannabis supplier. In addition to offering relief through accessible medical cannabis, the company is implementing components of the plant in its research on advanced drugs.
Althea has successfully expanded into the global cannabis market with a wholesale supply agreement to import a range of Althea-branded finished products for sale and distribution in South Africa beginning in Q2 2021. This agreement came on the heels of the news that the company is slated to become the first commercial supplier of Australian medicinal cannabis extract products to the German market, with all necessary licences for sale and distribution granted by the German government.
6. Zelira Therapeutics (ASX:ZLD)
Market cap: AU$113.79 million
Zelira Therapeutics’ efforts are on unmet clinical needs and on using medicinal cannabis to treat a range of diseases and disorders. Its most common target areas include pain, anxiety and sleep.
Zelira is largely focused on developing treatment options using plant-based medicinal marijuana, and currently has three clinical-stage programs with a focus on insomnia, autism and opioid reduction. The company is also conducting a pre-clinical research program to test cannabinoids in breast, brain and pancreatic cancer.
7. Medlab Clinical (ASX:MDC)
Market cap: AU$75.51 million
Medlab Clinical is a medical research and development company focused on novel biotherapeutics such as nutraceuticals and pharmaceuticals. The company is also developing pharmaceutical cannabis products.
In early 2020, Medlab Clinical launched the NanaBis Observation Study in Australia. NanaBis is a cannabis-based pain treatment drug that may prove useful as an alternative to opioid medication. It is also being used to investigate cancer pain management.
8. BOD Australia (ASX:BDA)
Market cap: AU$49.25 million
BOD Australia is focused on cannabis and hemp-related products. It develops, distributes and markets health and skincare products created using plant-based extracts in Australia. The company secured a foothold in the European cannabis market in 2020 with a AU$200,000 purchase order for four Swiss-branded hemp seed oil products to be sold in France, the Netherlands and the UK.
BOD Australia’s reach in Australia ranges from selling prescription and over-the-counter products to more than 1,000 outlets, such as pharmacies, retail stores and healthcare chains. It also has distribution agreements with two pharmacy wholesalers in Australia.
9. IDT Australia (ASX:IDT)
Market cap: AU$42.47 million
One of Australia’s oldest listed life science companies, IDT Australia is a pharmaceutical manufacturing company with extensive experience in the development and production of pharmaceutical products. Through its GMP-compliant facilities, the company provides full-scale services for new drug development, plus scale-up and commercial active drug manufacturing for local and international clients.
IDT Australia’s clients include Cann Group; IDT Australia is the manufacturer of the medical cannabis products that are a part of two of Cann Group’s export supply agreements with European and UK partners.
10. MMJ Group Holdings (ASX:MMJ)
Market cap: AU$31.04 million
MMJ Group Holdings has a wide range of cannabis investments, including healthcare products, technology, infrastructure, logistics, processing, cultivation, equipment, retail and research and development.
Among other companies, it has invested in Harvest One Cannabis (TSXV:HVT,OTCQB:HRVOF), which develops health and wellness products; Fire & Flower Holdings (TSXV:FAF,OTCQX:FFLWF), a recreational cannabis retailer that’s developed a variety of cannabis products and accessories; and MediPharm Labs (TSXV:LABS,OTQQX:MEDIF), a cannabis extraction company that received its cannabis oil production licence from Health Canada in 2018. MediPharm Labs has launched cannabis extraction services in Australia.
The presence of these ASX-listed cannabis companies shows that the cannabis industry in Australia is undoubtedly growing, as are investment opportunities in Australia’s cannabis industry. While recreational marijuana remains illegal in the land down under, the medical cannabis industry is thriving, making that side of the sector worth considering.
So far, Australia has no timeline attached to the legality of recreational use of marijuana, but it will be a story to watch over the coming years for those interested in the space.
Want more details? Check out these articles for more INNdepth coverage:
- Australia Cannabis Investing: What You Need to Know
- Guide to Investing in Cannabis Stocks on the ASX
Want an overview of investing in cannabis stocks? Check out Australian Cannabis Outlook 2021.
Since the legalisation of medical cannabis in 2016, Australia has been steadily developing its marijuana industry — and it’s been attracting attention from international players and investors.
With a quickly growing population of over 25 million people and a robust agricultural industry, the country is positioned to mould itself into a major force in the international cannabis space.
Here the Investing News Network takes a look at how the cannabis industry in Australia has been shaping up since legalisation and what these developments could mean for investors. Read on to see what you need to know about investing in cannabis down under.
Australia cannabis investing: Market overview
As mentioned, Australia’s parliament passed legislation to allow the cultivation of cannabis for medicinal and research purposes in 2016 by amending the Narcotic Drugs Act 1967. Cannabis companies have been cropping up in the country in the years since then.
While the cannabis industry is still young, Australia’s agricultural sector is well established. According to the Australian Bureau of Agricultural and Resource Economics and Sciences, the nation’s agriculture output is valued at AU$61 billion and is one of the largest contributors to GDP. The country’s agriculture export prowess means it may be able to capitalise on the trend of moving medical marijuana products internationally.
Recreational cannabis use isn’t legal in most parts of Australia. The exception is the Australian Capital Territory, which in early 2020 made it legal to possess and personally use small amounts of cannabis. That said, according to the Australian Institute of Health and Welfare (AIHW), cannabis is the most widely used illicit drug in the country. In a report, the AIHW notes that 85 percent of Australians now favour cannabis use for medical purposes, up from 69 percent in 2013.
Medical cannabis in the country is overseen by the Office of Drug Control, which issues three types of licences: research, manufacturing of a drug or product and cultivation or production of medical cannabis. As of November 2020, a total of 13 research licences, 29 cannabis cultivation or production licences and 33 manufacturing licences were held by medical cannabis companies in Australia.
Medical cannabis users do face a bit of difficulty accessing the drug. Patients can only receive medicinal cannabis products via a specialist and then may have to wait up to a month for government approval.
Some of the largest names in Canada’s cannabis landscape, such as Aurora Cannabis (NYSE:ACB,TSX:ACB) and Canopy Growth (NYSE:CGC,TSX:WEED), have substantial stakes in Australian companies. In 2018, Canopy launched Spectrum Cannabis Australia, a medical cannabis company.
In early 2019, Spectrum received its first shipment of medical cannabidiol (CBD) oil and began sales. Its goal is to support patients through imports until domestic facilities are working at full capacity.
Australia cannabis investing: How to invest
Since the country’s cannabis space is still in its early stages, the Australian market hasn’t yet reached its peak. However, more cannabis stocks are expected to list on the Australian Securities Exchange (ASX) in the future, which means more investment opportunities.
While Hemp Food Australia manufactures and distributes hemp food and skincare products, Elixinol is a retail provider on the CBD side of things, with dietary supplements and topical cannabis products. Elixinol has focused on building a solid global footprint with operations in the Americas, Europe and Asia.
In its Q3 2020 quarterly report, Elixinol said that revenues across its business units increased by 18 percent over the previous quarter, with 25 percent of the company’s global sales coming from e-commerce and 65 percent of global sales associated with higher-margin products.
Another big player in the Australian space is Cann Group (ASX:CAN,OTC Pink:CNGGF). Established in 2014, Cann Group was the first cannabis company to be issued a cannabis research licence and the first to be issued a medical cannabis cultivation licence by the Australian government.
It’s since worked to develop and supply cannabis, cannabis resin and medical cannabis products to patients for everything from multiple sclerosis to chronic pain.
In an agreement announced in November 2020, Cann Group secured a AU$50 million loan from National Australia Bank to fund a first stage expansion of its new Mildura growing facility in Victoria. Once completed, Cann Group will have the capacity to produce 12,500 kilograms per year of dry cannabis flower for international and domestic medical cannabis markets. This move puts Cann Group ahead in terms of production in a market that is still largely driven by imports.
There is also Althea Group (ASX:AGH), a producer, supplier and exporter of pharmaceutical-grade medicinal marijuana; it received its licence to cultivate medical cannabis in 2018. Currently, the company operates in regulated medical cannabis markets, including Australia and the UK.
In late 2020, the company received approval to sell cannabis products in Germany. The approval made Althea Germany’s first commercial supplier of made-in-Australia medical cannabis products. The German medical cannabis market is expected to be worth approximately AU$2.4 billion by 2025, as per the Market Herald.
Althea has made outreach an important part of its business model, as shown by its Althea Concierge platform, a free online service that allows healthcare professionals to access treatment plans with information about specific Althea marijuana products.
Australia cannabis investing: Future outlook
In 2019, the medical cannabis industry in Australia was valued at a slight US$171.7 million, but a forecast from Prohibition Partners, a market consultancy for the cannabis sector, projects huge growth in value over the next five years. By 2024, the total legal cannabis market in Australia is expected to hit US$1.23 billion.
Australia’s domestic market may be “somewhat capped by the region’s population.” However, Prohibition Partners points out that “overseas exports represent an opportunity for the region to significantly increase its value and establish a strong presence in the global market.”
Alongside the legalisation of medical cannabis was the legalisation of overseas exports in 2018, and Australia has big plans for the growth of its international presence. “We’d like to be potentially the world’s number one supplier,” said Australian Health Minister Greg Hunt on a local radio station.
Because of its proximity to the region, Australia is also well positioned to break into the burgeoning Asian market, which has become more attractive since the legalisation of medical marijuana in South Korea and Thailand. In response, some companies in Australia, such as Cann Group, have already made investments towards building larger facilities to meet the demand.
There’s also been talk about the legalisation of cannabis for recreational use in response to growing support for complete cannabis legalisation across the country. As noted, the Australian Capital Territory recently became the country’s first state to make it legal to grow or possess cannabis for personal use.
Overall, while recreational marijuana is still illegal in Australia, the growth of the country’s medical cannabis industry — and the Australian marijuana companies that exist within it — is a growing opportunity.
This is an updated version of an article first published by the Investing News Network in 2019.
Don’t forget to follow us @INN_Australia for real-time news updates!
Securities Disclosure: I, Melissa Pistilli, hold no direct investment interest in any company mentioned in this article.
Canada’s legal cannabis industry has experienced significant growth in the past few years. For those interested in investing in cannabis, a slew of marijuana companies have broken into the big leagues of market trading to become TSX cannabis stocks.
The TSX offers a new venue for cannabis ventures, and big names in the cannabis industry have made the cut, including massive licensed producers expanding their product offerings and brands.
These companies are leaders in the industry thanks to their rapid growth and large-scale developments.
For those interested in how to invest in cannabis, here the Investing News Network offers a growing list of all the cannabis-related companies listed on the TSX in alphabetical order.
Alcanna (TSX:CLIQ,OTC Pink:LQSIF)
Alcanna is an alcohol retail operator first and foremost, but thanks to an investment from Aurora Cannabis (TSX:ACB,NYSE:ACB), the company now also manages marijuana retail shops across the country under the retail brand name Nova Cannabis.
Aleafia Health (TSX:ALEF,OTCQX:ALEAF)
After completing a key acquisition, the firm was able to reach the TSX and gain a spot amid some of the top cannabis producers in Canada. Aleafia Health has a direct focus on the health and wellness space and its relationship with cannabis products.
Aphria was one of the first cannabis companies to reach the TSX and help solidify the growth of the marijuana industry. After undergoing a management change, the firm has maintained attention to its scale by growing its operations and international ventures.
Aurora Cannabis has secured a spot among the leading producers of marijuana in Canada, and has operations across the globe. The company has continued a steady path of acquisitions for players involved in all parts of the supply chain and development of marijuana technology.
Avicanna is a Canadian company working on the development of plant-derived cannabinoid-based products. The two subsidiaries of the company are licensed to cultivate and process cannabis for the production of cannabis extracts and purified cannabinoids.
Canopy Growth (TSX:WEED,NYSE:CGC)
Canopy Growth is one of the largest leading Canadian cannabis producers, with investments across the entire sector. The firm has a significant investment from alcohol-maker Constellation Brands (NYSE:STZ).
Canopy Rivers (TSX:RIV,OTC Pink:CNPOF)
As a venture capital firm specializing in cannabis, TSX cannabis stock Canopy Rivers invests in innovators across the marijuana value chain.
Cardiol Therapeutics (TSX:CRDL,OTCQX:CRTPF)
Cardiol Therapeutics is working on the development of medicines based on pharmaceutical-grade cannabidiol (CBD) and refining the production of lab-made elements of cannabis for medical use.
Charlotte’s Web Holdings (TSX:CWEB,OTCQX:CWBHF)
This Colorado-based company operates as a hemp producer distributing novelty products in the legal US market. Shares of Charlotte’s Web Holdings reached the TSX after regulators gained more clarity on the legal status of hemp in the US.
Cronos Group (TSX:CRON,NASDAQ:CRON)
Cronos Group is a leading marijuana firm with a blockbuster investment deal from Altria Group (NYSE:MO), one of the biggest tobacco producers in the world. The firm, like many other producers, has expressed interest in entering the US cannabis market at an appropriate time.
Delta 9 Cannabis (TSX:DN,OTCQX:VRNDF)
TSX cannabis stock Delta 9 Cannabis is a vertically integrated cannabis company selling cannabis products through its wholesale and retail sales channels.
Fire & Flower Holdings (TSX:FAF,OTCQX:FFLWF)
Fire & Flower Holdings is a licensed cannabis retailer that owns cannabis retail store licences in the Canadian provinces of Alberta, Saskatchewan, Manitoba and Ontario, as well as the Yukon.
Similar to its producer peers, HEXO was able to secure a partnership with an established beverage maker to develop cannabis-infused drinks, thanks to a joint venture with Molson Coors Brewing Company (NYSE:TAP).
InMed Pharmaceuticals (TSX:IN,NASDAQ:INM)
InMed Pharmaceuticals operates as a biopharmaceutical company, but its focus is set on the development of CBD-based therapeutics for disease treatment. Its pipeline has three candidates.
MediPharm Labs (TSX:LABS,OTCQX:MEDIF)
MediPharm Labs, another TSX cannabis stock, is a cannabis extraction company working on offering pharmaceutical-grade cannabis oils and concentrates to be used for infused products. The firm expects to process 250,000 kilograms of dry cannabis per year for extraction.
Neptune Wellness Solutions (TSX:NEPT,NASDAQ:NEPT)
Neptune Wellness Solutions is a company working in the extraction market alongside the marijuana space for novelty products. The firm also produces cannabis capsules using Licaps technology.
OrganiGram Holdings (TSX:OGI,NASDAQ:OGI)
Organigram Holdings is a leading Canadian licensed producer of high-quality medical and recreational cannabis. Outside Canada, it is developing international partnerships to extend its global footprint.
The Green Organic Dutchman (TGOD) (TSX:TGOD,OTCQX:TGODF)
After a successful capital raising, TGOD reached the TSX with promises of organic cannabis production and cost-effective operations. It touts an international portfolio with operations in Europe and Latin America.
The Supreme Cannabis Company (TSX:FIRE,OTCQX:SPRWF)
The Supreme Cannabis Company has earned a reputation as a dedicated producer whose operations are growing at a steady scale. This company has a focus on brand development and an interest in international plays for the cannabis market.
The Valens Company (TSX:VLNS,OTCQX:VLNCF)
The Valens Company is a vertically integrated provider of cannabis products, and is well positioned to become a leader in the emerging global-wide cannabis nutraceuticals market, which includes cannabis oils, extracts, beverages and edibles.
Village Farms International (TSX:VFF,NASDAQ:VFF)
TSX cannabis stock Village Farms International is a vertically integrated greenhouse grower across North America. The company decided to enter the cannabis space through a 50/50 joint venture for the management of cannabis grower Pure Sunfarms.
VIVO Cannabis (TSX:VIVO,OTCQX:VVCIF)
VIVO Cannabis is a Canadian licensed producer of medical and recreational cannabis.
Zenabis Global (TSX:ZENA)
The resulting company from a reverse takeover between Sun Pharm Investments and Bevo Agro, this cannabis producer offers consumers a variety of recreational products.
Want more details on Canadian cannabis stocks? Check out these articles for more INNdepth coverage:
- CSE Marijuana Stocks
- Cannabis Companies: Stocks on the TSXV
- Cannabis Investment: Canadian Cannabis Stocks
Want an overview of investing in cannabis? Check out Investing in the Cannabis Industry
The potential for new disease research and treatments is expanding thanks to the global adoption of marijuana for medical purposes.
As more countries open the doors to the use and investigation of cannabis, medical applications for the drug are set to expand — indeed, the substance has already shown much promise.
However, in terms of treating skin cancer patients, currently the promise of cannabis outpaces any medically confirmed results or applications.
Though there may be individual cases crediting the drug, cannabis and its derivatives are not being applied to treat skin cancer — at least not yet. Read on to learn about the current situation and future possibilities.
Skin cancer, cannabis and medical research
According to the American Cancer Society, skin cancer is the most common type of cancer, accounting for over 5 million cases per year. This category holds many different variations, but the main three types are basal cell carcinomas, squamous cell carcinomas and melanomas; the rest are considered rare.
Melanomas develop in specific areas like the neck and face and can be more serious than their counterparts. Basal and squamous cancer cells, on the other hand, develop based on a person’s sun exposure and mostly appear on the head and neck.
The Canadian Cancer Society states that treatments for non-melanoma skin cancer include surgery, radiation therapy, photodynamic therapy and drug therapy, including the use of topicals.
In the future, cannabis and cancer could be paired up as more research across the globe begins to take place and companies look for new medications and formulations, boosted by the early successes of the drug.
Changes are happening slowly, with one serious improvement being when GW Pharmaceuticals (NASDAQ:GWPH) obtained approval in the US for its cannabidiol (CBD) solution, which treats seizures associated with Lennox-Gastaut syndrome or Dravet syndrome in toddlers.
After going through its clinical trials, the company’s Epidiolex drug received approval from the US Food and Drug Administration, signaling that top medical agencies are ready to confirm the medical prowess of cannabis and its derivatives for the benefit of patients.
Cannabis entering the skincare space
Looking more specifically at cannabis and skin ailments, the National Eczema Association has vouched for CBD as an option in the treatment of eczema, a skin disease that affects over 30 million people in the US.
“It has long been observed that cannabinoids possess anti-inflammatory, antimicrobial and anti-itch qualities,” the Independent reported.
A study from the the University of Colorado School of Medicine is looking further into the use of CBD for patients with psoriasis or eczema who have tried using topical steroids or topical immunomodulators.
Robert Dellavalle, professor of dermatology with the University of Colorado, told Inside Science that CBD products are growing in popularity, but the results are not being collected as properly as they could be.
“I believe it’s a wide-open horizon with tremendous potential that needs to be investigated, but there are a number of regulatory hurdles that need to be overcome and that’s where we are,” he said.
A medical study from the University of Colorado’s Anschutz Medical Campus shows the anti-inflammatory sensibilities of cannabinoids are the main reason why cannabis may be potent in combating skin diseases.
“And while this research is still relatively formative, the results achieved so far clearly indicate its value and the promising potential of cannabis as effective medicine,” Tilray states.
Dave Berg, chief technology officer for software company Strainprint, told the Investing News Network the lack of sophisticated research has impacted the development of novel therapies for patients using cannabis.
“It’s been very difficult for people to study cannabis in a clinical way, but there’s been a ton observational data … There’s no really strong observational data set that allows us to make proper decisions,” Berg said.
In an effort to increase the research options available for cannabis, the Canadian federal government announced in 2018 that it would spend C$10 million over five years in order to assess the impact of cannabis use on the mental health of Canadians.
The government also promised C$10 million to the Canadian Center on Substance Use and Addiction for research purposes.
CBD skincare products getting traction
Amid developments geared at solving specific skin issues, more general CBD skincare products are also gaining popularity among many consumers.
For example, the introduction of cosmetics with cannabis elements, supported by Canadian licensed producers, is another upcoming element for the skin treatment segment of consumers. While not medical, this avenue does offer more options in terms of cannabis uses.
The endorsement from consumers for CBD ointments and other topicals for skincare has been documented with multiple products launched in the fractured US cannabis market.
One downside of the growth in these products is that it has led companies to make more and more claims about how these items can help with skin conditions. One study from the Journal of the American Medical Association warns that CBD products are often mislabeled online.
Takeaway on cannabis and skin cancer
In order for skin cancer patients to see the potential benefits from treatment with medical cannabis, much still has to change in Canada and abroad.
As the medical and recreational sections of the cannabis space continue drifting apart thanks to legalization efforts, the medical space should get more time to properly research and investigate the drug’s applications.
The early position CBD has gained in terms of skin maintenance and treatment could lead to further research on its impact on more serious diseases.
What’s more, GW Pharmaceuticals’ success, along with increased awareness of the medical benefits of cannabis, is moving the needle on research efforts geared at finding out how capable the drug will be in the medical space.
Want more details? Check out these articles for more INNdepth coverage:
Want an overview of investing in cannabis stocks? Check out Investing in the Cannabis Industry
The growth of the cannabis industry has made it possible for companies to offer many different investment opportunities through the major exchanges in Canada.
Previously known as the Canadian Venture Exchange, the TSX Venture Exchange is the sibling of Canada’s main listings board, the larger Toronto Stock Exchange.
For those interested in investing in cannabis companies, this exchange offers a variety of cannabis-related businesses, from growers to biotech companies looking for cannabinoid therapies.
Here the Investing News Network offers investors a growing list of all cannabis-related companies listed on the TSXV. Read on to learn more about them and their businesses.
This company is a marijuana producer looking to offer a variety of products for the recreational market in Canada, including for the health and wellness industry. 48North is a licensed outdoor grower of cannabis.
Auxly Cannabis Group (TSXV:XLY,OTCQX:CBWTF)
Created by Chuck Rifici, co-founder of Tweed, Auxly Cannabis Group operates as a cannabis streaming investment firm looking to boost various plays related to the sector.
Avricore Health (TSXV:AVCR,OTC Pink:AVCRF)
While Avricore Health operates as a healthcare technology company, in 2017 the firm made a deal with Emerald Health Therapeutics (TSXV:EMH,OTCQX:EMHTF) for the right to develop and sell endocannabinoid products in Canada to licensed pharmacies.
CanadaBis Capital (TSXV:CANB)
This cannabis company is targeting the Canadian market through a business model that is focused on cultivation, research, product development, retail and hemp.
Emerald Health Therapeutics
This Canadian cannabis company holds a variety of growing assets in the country. The firm holds a 50/50 joint venture for the management of a grower in BC with Village Farms International (TSX:VFF,NASDAQ:VFF).
EnWave (TSXV:ENW,OTC Pink:NWVCF)
EnWave is a technology company that has centered itself in the cannabis business thanks to its Radiant Energy Vacuum drying technology for organic materials. It effectively decreases the time from the harvest to the sale of cannabis products.
Through its partners, investment firm Elixxer presently has significant interests in Australia, Jamaica, Switzerland, Italy and Canada.
Eve & Co. (TSXV:EVE,OTCQX:EEVVF)
Eve & Co. is a Canadian cannabis producer that, thanks to its subsidiary Natural MedCo, is targeting female consumers, specifically with premier brands.
Experion Holdings (TSXV:EXP,OTCQB:EXPFF)
Formerly known as Viridium Pacific Group, this cannabis investment firm holds a portfolio of assets, including its licensed producer Experion Biotechnologies in BC.
The Flowr Corporation (TSXV:FLWR,OTC Pink:FLWPF)
The Flowr Corporation is a vertically integrated cannabis company working on the cultivation and sale of medical and recreational marijuana in Canada.
FluroTech is a technology company working on a cost-effective testing platform for the cannabis industry at large. The company’s proprietary CompleTest employs fluorescence spectroscopy technology to measure the specific contents of the product.
GTEC Holdings (TSXV:GETC,OTCQB:GGTTF)
This Kelowna-based cannabis company is vertically integrated, with operations in the cultivation, extraction and analytical testing sectors. The company is also pursuing retail operations through various investments.
Harvest One Cannabis (TSXV:HVT,OTCQX:HRVOF)
Harvest One Cannabis is a cannabis company with production and assets spread across Canada, Europe, Israel and Australia. The company gains its reach thanks to its three subsidiaries: United Greeneries, Satipharm and Dream Products.
Hill Street Beverage Company (TSXV:BEER)
This beverage maker has made its name thanks to its development of non-alcoholic beverages. Now the firm will offer consumers cannabis-infused drinks.
INDIVA is a company focused on the supply of medical cannabis. Through an acquisition, it holds a licensed producer with an indoor cannabis facility in Ontario.
Khiron Life Sciences (TSXV:KHRN,OTCQB:KHRNF)
Khiron Life Sciences is a Colombia-based cannabis company raising capital in Canada. The firm has declared that it will seek to expand its presence through Latin America, including Mexico.
Meta Growth (TSXV:META)
This company is a retail operator managing cannabis shops across Canada. Meta Growth manages two recreational store brands: Meta Cannabis Supply and NewLeaf Cannabis.
Namaste Technologies (TSXV:N,OTCQB:NXTTF)
After a tumultuous management change, Namaste Technologies has centered back on its investments and the development of its marijuana play, which includes its online platform of cannabis consumer information.
Naturally Splendid Enterprises (TSXV:NSP,OTCQB:NSPDF)
Naturally Splendid Enterprises is a biotech company developing hemp products for consumers in the health and wellness space. It plans to pursue a stake in the edible cannabidiol market as well.
Pharmacielo is another cannabis company originally from Colombia raising capital in the Canadian markets. The company is headquartered in Canada, but operates part of its marijuana growing in Colombia.
Radient Technologies (TSXV:RTI,OTCQX:RDDTF)
Radient Technologies is an extraction technology company that has dabbled in the cannabis sector thanks to a partnership with licensed producer Aurora Cannabis (TSX:ACB,NYSE:ACB).
Relevium Technologies (TSXV:RLV,OTC Pink:RLLVF)
Thanks to its subsidiary Biocannabix, this company has a cannabis play in the development of pharmaceutical-grade products infused with cannabinoid formulations.
SugarBud Craft Growers (TSXV:SUGR)
Like some other Canadian cannabis producers, this Alberta company specializes in growing and developing craft-style premium cannabis products.
Target Capital (TSXV:TCI)
Doing business as CBi2 Capital, this Alberta-based company’s investment strategy focuses on developing and managing a diversified portfolio of predominantly early stage cannabis opportunities.
Tetra Bio-Pharma (TSXV:TBP,OTCQB:TBPMF)
Tetra Bio-Pharma is researching and developing medicines based on cannabis and its elements.
Therma Bright (TSXV:THRM)
Therma Bright is a medical device company that has a subsidiary seeking to carve up a space in the technology space for medical and recreational marijuana thanks to its pain relief device.
WeedMD is another Canadian cannabis producer making product for the medical and recreational markets in Canada. Its subsidiaries include WeedMD Rx and CX Industries.
YSS (TSXV:YSS,OTC Pink:YSSCF)
YSS operates as an adult-use cannabis retailer with 17 stores in Canada.
Want more details on Canadian cannabis stocks? Check out these articles for more INNdepth coverage:
- CSE Marijuana Stocks
- Invest in Cannabis: TSX Cannabis Stocks
- Cannabis Investment: Canadian Cannabis Stocks
Want an overview of investing in cannabis? Check out Investing in the Cannabis Industry